Krilogy Financial’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.37M Sell
246,320
-1,844
-0.7% -$40.2K 0.16% 104
2026
Q1
$5.44M Buy
248,164
+3,228
+1% +$71.2K 0.18% 97
2025
Q4
$5.41M Buy
244,936
+8,911
+4% +$197K 0.18% 86
2025
Q3
$5.19M Buy
236,025
+33,129
+16% +$729K 0.19% 81
2025
Q2
$4.46M Buy
202,896
+4,438
+2% +$96.1K 0.26% 85
2025
Q1
$4.31M Buy
198,458
+6,976
+4% +$150K 0.28% 76
2024
Q4
$4.09M Sell
191,482
-1,512
-0.8% -$32.7K 0.27% 75
2024
Q3
$4.28M Buy
192,994
+8,170
+4% +$178K 0.29% 74
2024
Q2
$3.93M Buy
184,824
+347
+0.2% +$7.33K 0.29% 75
2024
Q1
$3.95M Buy
184,477
+4,287
+2% +$91.7K 0.3% 73
2023
Q4
$3.9M Buy
180,190
+9,606
+6% +$199K 0.33% 69
2023
Q3
$3.48M Buy
170,584
+3,423
+2% +$71.3K 0.32% 76
2023
Q2
$3.54M Buy
167,161
+689
+0.4% +$14.7K 0.32% 73
2023
Q1
$3.58M Buy
166,472
+99,941
+150% +$2.13M 0.3% 74
2022
Q4
$1.38M Sell
66,531
-87,254
-57% -$1.8M 0.13% 129
2022
Q3
$3.12M Buy
153,785
+1,424
+0.9% +$30.6K 0.37% 46
2022
Q2
$3.26M Buy
152,361
+58,390
+62% +$1.28M 0.38% 45
2022
Q1
$2.18M Sell
93,971
-66,031
-41% -$1.58M 0.22% 71
2021
Q4
$4.01M Buy
160,002
+245
+0.2% +$6.16K 0.4% 43
2021
Q3
$4.04M Buy
159,757
+2,930
+2% +$75.1K 0.4% 40
2021
Q2
$4M Sell
156,827
-3,762
-2% -$94.4K 0.4% 39
2021
Q1
$3.98M Buy
+160,589
New +$4.09M 0.42% 38

Other funds holding IBDV

Krilogy Financial's IBDV Position: Q2 2026 in Review

Krilogy Financial reduced its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 0.74% in Q2 2026, selling an estimated $40.2K and leaving 246,320 shares worth $5.37M. The position accounts for 0.16% of the portfolio, ranked #104.

Krilogy Financial first reported a position in IBDV in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.44M in Q1 2026. 349 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • Krilogy Financial held 246,320 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $5.37M as of Q2 2026.
  • Krilogy Financial sold 1,844 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $40.2K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.16% of Krilogy Financial's portfolio in Q2 2026, its #104 holding.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q1 2021 and has held it in 22 quarters since.
  • Krilogy Financial's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $5.44M in Q1 2026.
  • 349 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.